Response to zoledronic acid in patients with active Paget's disease of bone: A retrospective study

Response to zoledronic acid in patients with active Paget's disease of bone: A retrospective study

Background: Traditionally, bisphosphonates are used to treat active Paget's disease of bone (PDB). Intravenous zoledronic acid (ZA) is the most effective treatment option leading to sustained remission. Objective: The primary objective of this study was to analyze the effect of intravenous ZA i...

Full description

Bibliographic Details
Main Authors: Harsh Durgia, Jayaprakash Sahoo, Sadishkumar Kamalanathan, Rajan Palui, Ritesh Kumar, Dhanapathi Halanaik, Ramesh Ananthakrishnan, Gowri Sankar, Kalyani Sridharan, Henith Raj
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
bisphosphonates
paget's disease of bone
remission
zoledronic acid
Online Access:http://www.ijem.in/article.asp?issn=2230-8210;year=2019;volume=23;issue=1;spage=117;epage=121;aulast=Durgia

Internet

http://www.ijem.in/article.asp?issn=2230-8210;year=2019;volume=23;issue=1;spage=117;epage=121;aulast=Durgia

Similar Items